Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower ...
Hugely popular weight loss drugs known as GLP-1's are finally getting cheaper, well at least one is, and that's the case with ...
Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses ...
The new lower prices apply to some doses of Zepbound provided in vials but not the autoinjector pens.
Eli Lilly is unleashing new ammunition in its fight against cheaper, compounded versions of its obesity blockbuster Zepbound.
Consumer Reports warns there are important considerations, especially for older adults, before starting these treatments.
Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...
Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells ...